NCT04541212 - Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia | Biotech Hunter

Enrollment

169

Participants

Timeline

Start Date

December 2, 2021

Primary Completion Date

April 30, 2027

Study Completion Date

September 30, 2027

Conditions

Breast CancerLymphomaLeukemia

Interventions

DIAGNOSTIC_TEST

Cardiac Imaging

Cardiac Imaging: echography, ECG, MRI Blood tests: Lipid profile, hs-CRP, metabolic markers, HDL functionality, pharmacogenetic testing (optional), hematocrit, pregnancy test

OTHER

Data Collection

Collection of retrospective data

Trial Locations (6)

H2X0C1

Centre Hospitalier de l'université de Montréal (CHUM), Montreal

H3T 1M5

CIUSSS Ouest de l'ile de Montreal - St-Mary's Hospital, Montreal

Unknown

CIUSSS de l'Est-de-l'Île-de-Montréal - Hôpital Maisonneuve-Rosemont, Montreal

CIUSSS du Centre-Ouest de l'Île de Montréal - Jewish General Hospital, Montreal

Montreal Heart Institute, Montreal

J6V 2H2

CISSSS de Lanaudière_Hôpital Pierre LeGardeur (referring site), Terrebonne